People · Operator
Named in public records as an officer, director or promoter · active 2014–2025 · Biotech, Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Goodwin Biotechnology, Inc | — | Biotech | Series B | $30.7M | $7.7M | 2023 |
| Prairie Plant Systems Inc. | — | Biotechnology | Series A | $6.5M | $233.9M | 2016 |
| CanniMed Therapeutics Inc. | — | Biotechnology | Series A | $5.2M | $186.3M | 2016 |
| Nascent Biotech Inc. | — | Biotechnology | Pre-Seed | $543K | $30.0M | 2014 |
Brandon Price at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Brandon Price on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| John Knowles | 2 | 4 |
| Marianne Greer | 2 | 2 |
| Rob Duguid | 2 | 2 |
| Dwayne Lashyn | 2 | 2 |
| Bruce Mackler | 2 | 2 |
| Brent Zettl | 1 | 4 |
| Richard Hoyt | 1 | 3 |
| Nikhil Puri | 1 | 2 |
| Donald Ching | 1 | 2 |
| Larry Holbrook | 1 | 2 |
| Nikhil Emila Puri | 1 | 1 |
| Jerry Emila Liao | 1 | 1 |
| Lowell Holden | 1 | 1 |
| Sean Carrick | 1 | 1 |
| Mark Glassy | 1 | 1 |
| Doug Banzet | 1 | 1 |
| Brenton Zettl | 1 | 1 |
| Gulwant Bajwa | 1 | 1 |
| Doug Banset | 1 | 1 |
| Rick Hoyt | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.